Concepts (91)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pancreatic Neoplasms | 6 | 2023 | 218 | 1.230 |
Why?
|
| Carcinoma, Pancreatic Ductal | 3 | 2023 | 67 | 0.880 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2013 | 257 | 0.640 |
Why?
|
| ras Proteins | 2 | 2011 | 54 | 0.560 |
Why?
|
| Antineoplastic Agents | 5 | 2023 | 1019 | 0.550 |
Why?
|
| Deoxycytidine | 2 | 2018 | 38 | 0.520 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2013 | 25 | 0.400 |
Why?
|
| Oncogene Protein p21(ras) | 1 | 2011 | 2 | 0.360 |
Why?
|
| Proto-Oncogene Proteins c-pim-1 | 1 | 2011 | 5 | 0.340 |
Why?
|
| Radiation Tolerance | 1 | 2011 | 12 | 0.340 |
Why?
|
| Genes, ras | 2 | 2011 | 24 | 0.330 |
Why?
|
| Adenocarcinoma | 1 | 2011 | 291 | 0.280 |
Why?
|
| Neoplasms | 3 | 2011 | 1377 | 0.280 |
Why?
|
| Retroviridae | 1 | 2006 | 25 | 0.240 |
Why?
|
| Glycosyltransferases | 1 | 2025 | 9 | 0.230 |
Why?
|
| Neisseria gonorrhoeae | 1 | 2025 | 16 | 0.230 |
Why?
|
| Cell Wall | 1 | 2025 | 55 | 0.220 |
Why?
|
| Signal Transduction | 2 | 2011 | 2157 | 0.220 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 2025 | 171 | 0.210 |
Why?
|
| Cell Line, Tumor | 6 | 2023 | 2676 | 0.210 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2018 | 307 | 0.200 |
Why?
|
| Selenomethionine | 1 | 2002 | 13 | 0.190 |
Why?
|
| bcl-Associated Death Protein | 2 | 2013 | 7 | 0.190 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2002 | 41 | 0.190 |
Why?
|
| Transcription, Genetic | 1 | 2025 | 592 | 0.180 |
Why?
|
| Isoenzymes | 1 | 2002 | 168 | 0.180 |
Why?
|
| Neoplasm Invasiveness | 2 | 2013 | 290 | 0.170 |
Why?
|
| Bacterial Proteins | 1 | 2025 | 595 | 0.160 |
Why?
|
| Cell Proliferation | 4 | 2023 | 1455 | 0.160 |
Why?
|
| Colonic Neoplasms | 1 | 2002 | 223 | 0.160 |
Why?
|
| Phosphorylation | 2 | 2013 | 986 | 0.150 |
Why?
|
| RNA, Small Interfering | 3 | 2013 | 436 | 0.150 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 2 | 2011 | 56 | 0.140 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2018 | 157 | 0.130 |
Why?
|
| Chemoprevention | 1 | 2016 | 41 | 0.130 |
Why?
|
| Immunotherapy | 1 | 2016 | 144 | 0.110 |
Why?
|
| Humans | 9 | 2023 | 43102 | 0.110 |
Why?
|
| Epigenesis, Genetic | 1 | 2016 | 291 | 0.100 |
Why?
|
| Pyridazines | 1 | 2013 | 16 | 0.100 |
Why?
|
| Drug Synergism | 1 | 2013 | 195 | 0.090 |
Why?
|
| Gene Knockdown Techniques | 1 | 2013 | 189 | 0.090 |
Why?
|
| Imidazoles | 1 | 2013 | 142 | 0.090 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2013 | 185 | 0.090 |
Why?
|
| Gene Expression | 2 | 2013 | 701 | 0.090 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2011 | 23 | 0.080 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2023 | 159 | 0.080 |
Why?
|
| Apoptosis | 2 | 2018 | 1568 | 0.080 |
Why?
|
| Genome-Wide Association Study | 1 | 2011 | 423 | 0.080 |
Why?
|
| Transfection | 2 | 2006 | 532 | 0.070 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2018 | 1124 | 0.060 |
Why?
|
| Mutation | 1 | 2011 | 1177 | 0.060 |
Why?
|
| raf Kinases | 1 | 2006 | 7 | 0.060 |
Why?
|
| ral GTP-Binding Proteins | 1 | 2005 | 8 | 0.060 |
Why?
|
| Peptidoglycan | 1 | 2025 | 12 | 0.060 |
Why?
|
| RNA Interference | 1 | 2006 | 247 | 0.050 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2005 | 165 | 0.050 |
Why?
|
| Base Sequence | 1 | 2006 | 983 | 0.050 |
Why?
|
| Growth Inhibitors | 1 | 2023 | 29 | 0.050 |
Why?
|
| Prostaglandins | 1 | 2002 | 23 | 0.050 |
Why?
|
| Immunoenzyme Techniques | 1 | 2002 | 114 | 0.050 |
Why?
|
| Blotting, Northern | 1 | 2002 | 150 | 0.050 |
Why?
|
| Dinoprostone | 1 | 2002 | 64 | 0.050 |
Why?
|
| Cyclooxygenase 2 | 1 | 2002 | 107 | 0.040 |
Why?
|
| Cell Division | 1 | 2002 | 311 | 0.040 |
Why?
|
| Anti-Bacterial Agents | 1 | 2025 | 432 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 1 | 2002 | 508 | 0.040 |
Why?
|
| Animals | 2 | 2016 | 16992 | 0.040 |
Why?
|
| Blotting, Western | 1 | 2002 | 883 | 0.040 |
Why?
|
| Membrane Proteins | 1 | 2002 | 561 | 0.040 |
Why?
|
| Workflow | 1 | 2018 | 26 | 0.040 |
Why?
|
| Molecular Conformation | 1 | 2018 | 155 | 0.030 |
Why?
|
| Protein Kinases | 1 | 2018 | 100 | 0.030 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2018 | 127 | 0.030 |
Why?
|
| High-Throughput Screening Assays | 1 | 2018 | 74 | 0.030 |
Why?
|
| Time Factors | 1 | 2002 | 1857 | 0.030 |
Why?
|
| Structure-Activity Relationship | 1 | 2018 | 506 | 0.030 |
Why?
|
| Cell Survival | 1 | 2018 | 945 | 0.030 |
Why?
|
| Models, Molecular | 1 | 2018 | 876 | 0.030 |
Why?
|
| ral Guanine Nucleotide Exchange Factor | 1 | 2005 | 1 | 0.010 |
Why?
|
| Guanosine Triphosphate | 1 | 2005 | 18 | 0.010 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2005 | 28 | 0.010 |
Why?
|
| GTPase-Activating Proteins | 1 | 2005 | 29 | 0.010 |
Why?
|
| Neoplasm Transplantation | 1 | 2005 | 129 | 0.010 |
Why?
|
| Vesicular Transport Proteins | 1 | 2005 | 48 | 0.010 |
Why?
|
| Mice, SCID | 1 | 2005 | 158 | 0.010 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2005 | 82 | 0.010 |
Why?
|
| Protein Transport | 1 | 2005 | 296 | 0.010 |
Why?
|
| Carrier Proteins | 1 | 2005 | 321 | 0.010 |
Why?
|
| Protein Binding | 1 | 2005 | 1082 | 0.010 |
Why?
|
| Cell Line | 1 | 2005 | 1410 | 0.010 |
Why?
|
| Mice | 1 | 2005 | 6644 | 0.010 |
Why?
|